OK-432 and 5-fluorouracil, doxorubicin, and mitomycin C (FAM-P) versus FAM chemotherapy in patients with curatively resected gastric carcinoma: a randomized Phase III trial (Q77596963)
Jump to navigation
Jump to search
scientific article published on 01 November 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | OK-432 and 5-fluorouracil, doxorubicin, and mitomycin C (FAM-P) versus FAM chemotherapy in patients with curatively resected gastric carcinoma: a randomized Phase III trial |
scientific article published on 01 November 1998 |
Statements
OK-432 and 5-fluorouracil, doxorubicin, and mitomycin C (FAM-P) versus FAM chemotherapy in patients with curatively resected gastric carcinoma: a randomized Phase III trial (English)
S Y Kim
H C Park
C Yoon
H J Yoon
Y M Choi
1 November 1998